Impact of emtricitabine/tenofovir (FTC/TDF) on renal function in antiretroviral-na ve patients >= 50 years - TRIP study

Blanco, J.; Castano, M.; Olalla, J.; Domingo, P.; Arazo, P.; Gomez-Sirvent, J.; Riera, M.; Pulido, F.; Vera, F.; Vergara, A.; Aguirrebengoa, K.; Portilla, J.; Pedrol, E.

doi:10.7448/IAS.15.6.18312

Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/12980

View

000320654200098.pdf (180.1Kb)

Identifiers

URI: http://hdl.handle.net/20.500.13003/12980

DOI: 10.7448/IAS.15.6.18312

eISSN: 1758-2652

WOS ID: 000320654200098

Embase PUI: L71227678

Metrics

Export

External links

Publication date

2012-11

Document type

contribution to journal

Citation

Blanco J, Castano M, Olalla J, Domingo P, Arazo P, Gomez-Sirvent J, et al. Impact of emtricitabine/tenofovir (FTC/TDF) on renal function in antiretroviral-na ve patients >= 50 years - TRIP study [meeting abstract]. J Int AIDS Soc. 2012 Nov;15:46-7.

Publisher version

https://dx.doi.org/10.7448/IAS.15.6.18312

This item appears in following Docusalut collections

Hospital Universitario Son Espases - HUSE > Comunicación científica

This item's license is described as Attribution 3.0 Unported